http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2355294-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_150161211982af759380e1b4629354fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a035e8eff936308e0fdeed35fd46dd90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate | 2007-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae99e15f9178955dcef8b759c3cdad40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ee53420787fd88d803ab7d95c10d72d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4e3011dff878065ea1ef2164735099 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_544963b99ee4e14791f2d8733ac73ade http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07bfc395b82eed056e52b1a8036b6f8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaa250aff0a518c336f16d02036c16e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba00cf741f8333d96a5157ff59537177 |
| publicationDate | 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2355294-C1 |
| titleOfInvention | Method for stomatologic treatment scheduling subject to patient functional status |
| abstract | FIELD: medicine, stomatology. n SUBSTANCE: tooth and jaw system examination is conducted, and dental pathology is detected; if there is any, patient's metabolic state is studied, using optical spectral absorption measurement of hemolyzed blood samples in wavelength ranges: 200-240 nm, 260-280 nm, 340-345 nm, and 410-420 nm, in course of five steps. The first one is realised before treatment, the second - after one week, the third - after two weeks, the fourth - after one month, the fifth - after three months of treatment. Then amplitude values and tendencies of optical absorption peaks in the patient blood samples relative to initial data are determined, whereupon metabolism dynamics is assessed. Two mark scales are arranged, each including three state levels; the first scale being based on spectrometry data in wavelength ranges as indicated above. In 200-240 nm range, readings 1.1 to 1.5 optical density units (ODU) are considered as physiological optimum and marked as "0"; in 200-240 nm range, readings 1.5 to 1.7 and 0.9 to 1.1 ODU are considered as lowered metabolism and marked as "1", in 200-240 nm range, readings < 0.9 and > 1.7 ODU are considered as distinctly lowered metabolism and marked as "2". In 260-280 nm range, readings 0.5 to 0.6 ODU are considered as physiological optimum and marked as "0"; in 260-280 nm range, readings 0.2 to 0.4 and 0.6 to 0.8 ODU are considered as lowered metabolism and marked as "1", in 260-280 nm range, readings < 0.2 and > 0.8 ODU are considered as distinctly lowered metabolism and marked as "2". In 340-345 nm range, readings 0.3 to 0.4 ODU are considered as physiological optimum and marked as "0"; in 340-345 nm range, readings 0.18 to 0.3 and 0.4 to 0.56 ODU are considered as lowered metabolism and marked as "1", in 340-345 nm range, readings < 0.18 and > 0.56 ODU are considered as distinctly lowered metabolism and marked as "2". In 410-420 nm range, readings 1.1 to 1.7 ODU are considered as physiological optimum and marked as "0"; in 410-420 nm range, readings 0.9 to 1.1 and 1.7 to 1.85 ODU are considered as lowered metabolism and marked as "1", in 410-420 nm range, readings < 0.9 and > 1.85 ODU are considered as distinctly lowered metabolism and marked as "2". The second scale is composed based on the first one data; the marks of 200-420 wavelength ranges being summed up. If the sum is zero to three, physiological optimum is stated and marked as "0"; if the sum is three to five, lowered metabolism is stated and marked as "1", if the sum is above five, distinctly lowered is stated metabolism and marked as "2". After realising metabolism analysis on each of the above steps, patients are divided in three groups: those having mark "0" are administered standard treatment procedure, those having mark "1" are recommended individual treatment schedule, those having mark "2" are examined as regards concomitant conditions, and thereupon are recommended individual schedule of concomitant diseases therapy and teeth treatment. n EFFECT: stomatologic therapy quality increasing due to individual schedule of the treatment, subject to patient functional state. n 6 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2779362-C1 |
| priorityDate | 2007-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 225.